THE SCIENTIFIC REVIEW PROCESS
What is The Scientific Review?
The Concern Foundation’s biennial Scientific Review is the process that determines which researchers receive Concern’s $60,000 Conquer Cancer Now Awards, and essentially, where all the money we raise goes.
Every two years, Concern flies in top researchers from all over the world who spend a weekend in Los Angeles for a rigorous process of reviewing the best of the best research applications that have been whittled down from nearly 200 cancer research applications that were received beginning in mid-September. These finalists will receive the Conquer Cancer Now Award. Concern Foundation has funded over 700 researchers through the Conquer Cancer Now Awards.
Why Do You Need a Scientific Committee to Review to Decide Who Receives a Grant?
We believe in transparency. In order to be transparent in our grant selection and fund disbursement, we have a longstanding unbiased scientific review committee. This Scientific “Peer” Review is a process that actually has very little to do with us at Concern so that the awards are truly given to the next generation of young and innovative cancer research scientists based solely on the merits of their proposal.
Who is on the Scientific Review Committee?
The committee is made up of established researchers from major cancer research institutions around the world. Many of the scientific review committee scientists are prior recipients of the Conquer Cancer Now Award who have made great advances in their field and continue to sit on the committee to help fund the next big idea in cancer research.
David Cobrinik, M.D., Ph.D.
Associate Professor of Research Ophthalmology and Biochemistry & Molecular Medicine, Cobrinik Laboratory
Children's Hospital Los Angeles
Don J. Diamond, Ph.D.
Professor, Department of Hematology & Hematopoietic Cell Transplantation
City of Hope National Medical Center
Sinisa Dovat, Ph.D., M.D.
Professor of Pediatrics, Pharmacology and Biochemistry and Molecular Biology, Four Diamonds Endowed Chair, Director of Translational Research and Developmental Therapeutics
Pennsylvania State University, College of Medicine, Department of Pediatrics, Children’s Hospital Division of Pediatric Hematology/Oncology
*Anat Erdreich-Epstein, M.D., Ph.D.
Associate Professor of Pediatrics and Pathology
Director, USC/CHLA Summer Oncology Research Fellowship Program
Neural Tumors Program, Basic and Translational Brain Tumor Research, Cancer and Blood Disease Institute, Division of Hematology-Oncology, Department of Pediatrics, Children's Hospital Los Angeles and Norris Comprehensive Cancer Center Keck School of Medicine, University of Southern California
Muller Fabbri, M.D., Ph.D.
Associate Professor, Leader Cancer Biology Program
University of Hawai’i Cancer Center
Michael Farrar, Ph.D.
Professor and Virginia and David C. Utz Land Grant Chair in Fundamental Immunobiology
Center for Immunology and Masonic Cancer Center, University of Minnesota
Michael Freeman, Ph.D.
Professor in the Departments of Surgery, Medicine and Biomedical Sciences at Cedars-Sinai Medical Center, and a professor in the Department of Medicine at the University of California, Los Angeles (UCLA).
Cedars-Sinai Medical Center
*Jennifer R. Grandis, M.D.
Robert K. Werbe Distinguished Professor
University of California San Francisco
Steve M. Kornblau, M.D.
Professor, Departments of Leukemia and Stem Cell Transplantation & Cellular Therapy
MD Anderson Cancer Center
Amy S. Lee, Ph.D.
Professor of Biochemistry and Molecular Medicine
Keck School of Medicine, University of Southern California
Prof. Ofer Mandelboim, Ph.D
The Concern Foundation Laboratories in the Lautenberg Center for Immunology and Cancer Research, Hebrew University, Hadassah Medical School, Jerusalem
Nouri Neamati, Ph.D.
John G. Searle Professor of Medicinal Chemistry, Rogel Cancer Center, University of Michigan
Edward V. Prochownik, M.D., Ph.D.
The Paul C. Gaffney Professor of Pediatrics and Professor of Microbiology & Molecular Genetics
Section of Hematology/Oncology, Rangos Research Center, Children's Hospital of Pittsburgh
Kathleen M. Sakamoto, M.D., Ph.D.
Shelagh Galligan Professor of Pediatrics, Division of Hematology/Oncology Stanford University School of Medicine
Eric Stanbridge, PhD.
Distinguished Research Professor, University of California, Irvine School of Medicine
Prof. Renata Stripecke, Ph.D.
Regenerative Immune Therapies Applied Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School
Prof. Eitan Yefenof, Ph.D.
Lautenberg Center, Concern Foundation Laboratories, Hebrew University, Jerusalem
*Review Committee Co-chairs
Back to Top